AU Patent

AU2023271739B2 — Therapeutic compounds useful for the prophylactic or therapeutic treatment of an HIV virus infection

Assigned to Gilead Sciences Inc · Expires 2025-08-21 · 1y expired

What this patent protects

#$%^&*AU2023271739B220250821.pdf##### ABSTRACT The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb): (Ia) (Ib) (IIa) ABSTRACT The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb): F F F F F N…

USPTO Abstract

#$%^&*AU2023271739B220250821.pdf##### ABSTRACT The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb): (Ia) (Ib) (IIa) ABSTRACT The present disclosure relates to a compound of formula (Ia), (Ib), (IIa), and (IIb): F F F F F N N F H F N CI O H N NII SN-N o F O=S F F (Ia) F F F F FIIII : N N F HF N CI O H N N SN-N O F O=S SS F F (Ib) F F F F N NF HF N CI HO N N N-N O F O= F 11 O (IIa) 20 23 27 17 39 27 N ov 2 02 3 A B S T R A C T T h e p r e s e n t d i s c l o s u r e r e l a t e s t o a c o m p o u n d o f f o r m u l a ( I a ) , ( I b ) , ( I I a ) , a n d ( I I b ) : 2 0 2 3 2 7 1 7 3 9 2 7 N o v 2 0 2 3 F F F F F N N F Z I H F N C I O H N N S N - N O F O S F F O ( I a ) F , F F F F N N F F Z I H N C I O Z I H N N S N - N O F O S F F O ( I b ) F F F F N N F Z I H F N C I O Z I H N N N - N S O O F O I S F O = ( I I a ) H:\Interwoven\NRPortbl\DCC\VZS\20024752_1.docx-3/26/2020 (IIb) which are useful in the treatment of a Retroviridae viral infection including an infection caused by the HIV virus. H:\Interwoven\NRPortbl\DCC\VZS\20024752_1.docx-3/26/2020 F F I'll F F = N NF F HN CI O HN NII N-N F Os FOF (IIb) which are useful in the treatment of a Retroviridae viral infection including an infection caused by the HIV virus.20 23 27 17 39 27 N ov 2 02 3 H : \ I n t e r w o v e n \ N R P o r t b I \ D C C \ V Z S \ 2 0 0 2 4 7 5 2 _ 1 . d o c x - 3 / 2 6 / 2 0 2 0 F N o v 2 0 2 3 F F . F N N F I Z H F N C I O Z I H N N N - N S 2 0 2 3 2 7 1 7 3 9 2 7 F O = S F O = = ( I I b ) w h i c h a r e u s e f u l i n t h e t r e a t m e n t o f a R e t r o v i r i d a e v i r a l i n f e c t i o n i n c l u d i n g a n i n f e c t i o n c a u s e d b y t h e H I V v i r u s .

Drugs covered by this patent

Patent Metadata

Patent number
AU2023271739B2
Jurisdiction
AU
Classification
Expires
2025-08-21
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.